AlloVir, Inc.

ALVR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12-$11-$10-$18
Dep. & Amort.-$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$0$10
Change in WC$0$0$0$4
Other Non-Cash$0-$2$2-$0
Operating Cash Flow-$11-$13-$7-$4
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$35$0$0$0
Inv. Sales/Matur.$0$0$0$5
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$35$0$0$5
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$4$0$4$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$107$0
Financing Cash Flow$0$0$107$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$46-$13$100$1
Supplemental Information
Beg. Cash$89$101$2$117
End Cash$43$89$101$118
Free Cash Flow-$12-$13-$7-$4